MEDFORD, N.Y.--(BUSINESS WIRE)--July 12, 2006--Chembio Diagnostics Inc. (OTCBB: CEMI - News) has submitted a CLIA Waiver Application for the Chembio HIV 1/2 STAT-PAK(TM) rapid diagnostic test on July 7th, 2006. The CLIA waiver, if granted, will allow Chembio to market to approximately 189,000 laboratory entities across the United States, including doctors' offices and clinics.
